Axon Partners Group (APG) Fair Value & Analysis
Industrials · ES · Market cap €87.0M
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from €18.93 to €21.90 (+15.7%) since Jun 23, 2026. Share price +3.6% over the past month.
Price vs Fair Value (12 months)
12‑month range €13.60 – €17.30 · fair‑value band €10.55 – €29.57 · the €17.30 price screens below the €21.90 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Axon Partners Group (APG) currently trades at €17.30, while our model-based Fair Value estimate is €21.90 — implying the stock looks roughly 26.6% undervalued today. We read business quality at 87/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Axon Partners Group generated revenue of €14.8M at a net margin of 29.8%. Revenue grew 21.6% year over year. The balance sheet holds a net cash position of €5.4M. The stock trades on a trailing P/E of 13.7. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Axon Partners Group, S.A. is a private equity and venture capital firm specializing in all stages from seed to growth capital, growth equity, startups, lower middle market, early stage, pre-IPO, IPO, post IPO, expansion, mid venture, late venture sustainability, debt instrument, private debt and fund of funds investment. Within fund of funds, the firm seeks to invest in all sectors and stages from early to growth and considers direct co-investments and secondary opportunities. Within fund of fund, the firm specializes in venture capital and it invests in ICT, digital, deep tech and life sciences in Pan-European region. Within fund of fund, the firm seeks to invest globally with the focus in European Union, United Kingdom, Nordics, Israel and the United States. The firm is sector agnostic with particular interest in enterprise-focused technology companies. The firm prefers to invest in consumer and technology focused companies, nanotechnology, biotechnology, Industrial, climate tech,…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Axon Partners Group reported revenue of €26.4M in FY2025 versus €13.5M in FY2021, a compound +18.2%/yr. Reported net income was €6.4M in FY2025, compounding +17.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Experian plc EXPGY | $32.96 | $29.60 | -10% |
| SGS SA SGSOF | $110.42 | $84.42 | -24% |
| Verisk Analytics, Inc VRSK | $181.73 | $89.91 | -51% |
| Equifax Inc EFX | $170.99 | $104.33 | -39% |
| Bureau Veritas SA BVRDF | $30.75 | $25.47 | -17% |
| Booz Allen Hamilton Holding BAH | $78.94 | $96.35 | +22% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Axon Partners Group (APG) undervalued?
What is the fair value of APG?
What is the quality score of APG?
What is the revenue of Axon Partners Group (APG)?
What is the net profit margin of APG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.